Go Pro

GenSight Biologics (GSGTF) News Today

GenSight Biologics logo
$0.09 0.00 (0.00%)
As of 09/2/2026

GenSight Biologics Latest News

Gensight Biologics SA GSGTF
GenSight Biologics SA (G49N) Gets a Hold from Kepler Capital
Kepler Capital Keeps Their Hold Rating on GenSight Biologics SA (G49N)
Kepler Capital Remains a Hold on GenSight Biologics SA (G49N)
Kepler Capital Sticks to Their Hold Rating for GenSight Biologics SA (G49N)
GenSight Biologics S.A. (SIGHT.PA)

GenSight Biologics Media Mentions By Week

GenSight Biologics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GSGTF
News Sentiment

0.00

0.78

Average
Healthcare
News Sentiment

GenSight Biologics News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GSGTF Articles
This Week

1

0

GSGTF Articles
Average Week

GenSight Biologics Trends on MarketBeat

This week vs. last week
Page Views
136
+39%
Get GenSight Biologics News Delivered to You Automatically

Sign up to receive the latest news and ratings for GSGTF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for GenSight Biologics dated 8/29/2026.
From Our Partners